Identifying and Tackling Emergent Vulnerability in Drug-Resistant Mycobacteria

详细信息    查看全文

• 作者：Jyothi Padiadpu ; Priyanka Baloni ; Kushi Anand ; MohamedHusen Munshi ; Chandrani Thakur ; Abhilash Mohan ; Amit Singh ; Nagasuma Chandra
• 刊名：ACS Infectious Diseases
• 出版年：2016
• 出版时间：September 9, 2016
• 年：2016
• 卷：2
• 期：9
• 页码：592-607
• 全文大小：827K
• ISSN：2373-8227

文摘

The global mechanisms and associated molecular alterations that occur in drug-resistant mycobacteria are poorly understood. To address this, we obtain genomics data and then construct a genome-scale response network in isoniazid-resistant Mycobacterium smegmatis and apply a network-mining algorithm. Through this, we decipher global alterations in an unbiased manner and identify emergent vulnerabilities in resistant bacilli, of which redox response was prominent. Using phenotypic profiling, we find that resistant bacilli exhibit collateral sensitivity to several compounds that block antioxidant responses. We find that nanogram/milliliter concentrations of ebselen, vancomycin, and phenylarsine oxide, in combination with isoniazid, are highly effective against Mycobacterium tuberculosis H37Rv and three clinical drug-resistant strains. Dynamic measurements of cytoplasmic redox potential revealed a surprisingly diminished capacity of clinical drug-resistant strains to counteract oxidative stress, providing a mechanistic basis for efficient and synergistic mycobactericidal activity of the drug combinations. Ebselen and vancomycin appear to be promising repurposable drugs.